Provided by Tiger Trade Technology Pte. Ltd.

Oculis

13.18
+0.09500.73%
Post-market: 13.250.0700+0.53%19:30 EDT
Volume:150.39K
Turnover:1.97M
Market Cap:813.63M
PE:-7.68
High:13.25
Open:13.10
Low:12.87
Close:13.09
52wk High:34.48
52wk Low:10.52
Shares:61.73M
Float Shares:53.44M
Volume Ratio:0.86
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7151
EPS(LYR):-2.3888
ROE:-43.70%
ROA:-24.95%
PB:2.98
PE(LYR):-5.52

Loading ...

Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema

GlobeNewswire
·
May 30

Oculis Holding AG trading halted, news pending

TIPRANKS
·
May 30

NASDAQ TRADE HALT HALT NEWS PENDING AT 02:43 PM

Reuters
·
May 30

Oculis quickly falls 26% to $22 per share

TIPRANKS
·
May 30

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
May 29

Oculis Holding Initiated at Buy by Guggenheim

Dow Jones
·
May 21

Guggenheim Initiates Oculis Holding at Buy With $75 Price Target

MT Newswires Live
·
May 21

Oculis initiated with a Buy at Guggenheim

TIPRANKS
·
May 21

Fujian Aims for Over 300 Billion Yuan in Photonics Cluster Revenue by 2030, Accelerates R&D on High-Speed Optical Modules

Deep News
·
May 19

Oculis Holding Is Maintained at Overweight by JP Morgan

Dow Jones
·
May 18

Oculis Holding (OCS) Gets a Buy from LifeSci Capital

TIPRANKS
·
May 16

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
May 16

Oculis AGM Backs All Proposals, Adds Veteran Biotech CFO to Board and Expands Capital Flexibility

TIPRANKS
·
May 15

Press Release: Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors

Dow Jones
·
May 15

Oculis Holding Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 13

Stock Track | Oculis Holding Plummets 5.05% Intraday Following Analyst Ratings

Stock Track
·
May 12

Oculis price target raised to $44 from $43 at BofA

TIPRANKS
·
May 12

Analysts Offer Insights on Healthcare Companies: Oculis Holding (OCS) and Apogee Therapeutics (APGE)

TIPRANKS
·
May 12

Oculis Holding (OCS) Gets a Buy from Chardan Capital

TIPRANKS
·
May 12

Oculis reports Q1 EPS (49c), consensus (41c)

TIPRANKS
·
May 12